Q9NZU7 (CABP1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 112.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Calcium-binding protein 1 Short name=CaBP1 Alternative name(s): Calbrain Caldendrin | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 370 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Modulates calcium-dependent activity of inositol 1,4,5-triphosphate receptors (ITPRs). Inhibits agonist-induced intracellular calcium signaling. Enhances inactivation and does not support calcium-dependent facilitation of voltage-dependent P/Q-type calcium channels. Causes calcium-dependent facilitation and inhibits inactivation of L-type calcium channels by binding to the same sites as calmodulin in the C-terminal domain of CACNA1C, but resulting in an opposit effects on channel function. Suppresses the calcium-dependent inactivation of CACNA1D By similarity. Inhibits TRPC5 channels. Prevents NMDA receptor-induced cellular degeneration By similarity. Ref.7 Ref.9 Ref.11 Ref.12 Ref.13 |
| Subunit structure | Homodimer; when bound to calcium or magnesium. Interacts (via C-terminus) with ITPR1, ITPR2 and ITPR3. This binding is calcium dependent and the interaction correlates with calcium concentration. An additional calcium-independent interaction with the N-terminus of ITPR1 results in a decreased InsP3 binding to the receptor. Interacts with CACNA1A (via C-terminal CDB motif) in the pre- and postsynaptic membranes. Interacts with CACNA1C (via C-terminal C and IQ motifs). The binding to the C motif is calcium independent whereas the binding to IQ requires the presence of calcium and is mutually exclusive with calmodulin binding. Interacts with CACNA1D By similarity. Interacts with TRPC5 (via C-terminus). Interacts (via EF-hands 1 and 2) at microtubules with MAP1LC3B. Interacts with MYO1C By similarity. Interacts (via EF-hands 1 and 2) with NSMF (via the central NLS-containing motif region), the interaction occurs in a calcium dependent manner after synaptic NMDA receptor stimulation and prevents nuclear import of NSMF By similarity. Ref.6 Ref.7 Ref.8 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 |
| Subcellular location | Cytoplasm › cytoskeleton. Cytoplasm › perinuclear region. Cell membrane; Lipid-anchor; Cytoplasmic side. Golgi apparatus. Cell junction › synapse › postsynaptic cell membrane › postsynaptic density. Note: L-CaBP1 is associated most likely with the cytoskeletal structures, whereas S-CaBP1 is localized at or near the plasma membrane. Ref.8 Ref.9 Isoform L-CaBP1: Cytoplasm › cytoskeleton. Note: L-CaBP1 is associated most likely with the cytoskeletal structures. Ref.8 Ref.9 Isoform S-CaBP1: Cytoplasm › cell cortex. Cell membrane; Lipid-anchor Probable. Note: S-CaBP1 is localized at or near the plasma membrane. Ref.8 Ref.9 |
| Tissue specificity | Retina and brain. Somatodendritic compartment of neurons. Calbrain was found exclusively in brain where it is abundant in the hippocampus, habenular area in the epithalamus and in the cerebellum. |
| Domain | EF-1 binds magnesium constitutively under physiological conditions, EF-3 and EF-4 bind calcium cooperatively and EF-2 binds neither calcium nor magnesium. |
| Post-translational modification | Phosphorylated. The phosphorylation regulates the activity. Ref.8 |
| Sequence similarities | Contains 4 EF-hand domains. |
| Caution | The interaction with CACNA1A is described as calcium independent in Ref.7 while it is shown to be acutely calcium dependent in Ref.9. Ref.6 describes a stimulatory effect of CABP1 during agonist-induced intracellular calcium signaling while Ref.9 and Ref.7 show an inhibitory effect. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CACNA1C | Q13936 | 4 | EBI-907894,EBI-1038838 |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] Note: Experimental confirmation may be lacking for some isoforms. | ||||||
| Isoform Caldendrin (identifier: Q9NZU7-4) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform L-CaBP1 (identifier: Q9NZU7-1) Also known as: Caldendrin-S2; The sequence of this isoform differs from the canonical sequence as follows: 1-143: Missing. 144-218: RPREALPAAA...RPMLSSAFGQ → MGNCVKYPLR...RKGFAENRQP | ||||||
| Note: Myristoylated on Gly-2. | ||||||
| Isoform S-CaBP1 (identifier: Q9NZU7-2) Also known as: Caldendrin-S1; The sequence of this isoform differs from the canonical sequence as follows: 1-203: Missing. 204-218: FLHRLRPMLSSAFGQ → MGNCVKYPLRNLSRK | ||||||
| Note: Myristoylated on Gly-2. | ||||||
| Isoform Calbrain (identifier: Q9NZU7-3) The sequence of this isoform differs from the canonical sequence as follows: 1-300: Missing. | ||||||
| Note: It is currently uncertain whether calbrain represent a spliced isoform. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Potential | ||||||||||||||||||||||||||||||||||
| Chain | 2 – 370 | 369 | Calcium-binding protein 1 | PRO_0000073513 | |||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||
| Domain | 225 – 260 | 36 | EF-hand 1 | ||||||||||||||||||||||||||||||||||
| Domain | 261 – 296 | 36 | EF-hand 2 | ||||||||||||||||||||||||||||||||||
| Domain | 302 – 337 | 36 | EF-hand 3 | ||||||||||||||||||||||||||||||||||
| Domain | 339 – 370 | 32 | EF-hand 4 | ||||||||||||||||||||||||||||||||||
| Calcium binding | 238 – 249 | 12 | 1 Ref.14 | ||||||||||||||||||||||||||||||||||
| Calcium binding | 315 – 326 | 12 | 2 Ref.14 | ||||||||||||||||||||||||||||||||||
| Calcium binding | 352 – 363 | 12 | 3 Ref.14 | ||||||||||||||||||||||||||||||||||
| Compositional bias | 45 – 48 | 4 | Poly-Pro | ||||||||||||||||||||||||||||||||||
| Compositional bias | 74 – 79 | 6 | Poly-Ala | ||||||||||||||||||||||||||||||||||
| Compositional bias | 86 – 164 | 79 | Pro-rich | ||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||
| Metal binding | 238 | 1 | Magnesium | ||||||||||||||||||||||||||||||||||
| Metal binding | 240 | 1 | Magnesium | ||||||||||||||||||||||||||||||||||
| Metal binding | 242 | 1 | Magnesium | ||||||||||||||||||||||||||||||||||
| Metal binding | 244 | 1 | Magnesium; via carbonyl oxygen | ||||||||||||||||||||||||||||||||||
| Metal binding | 315 | 1 | Calcium 1 | ||||||||||||||||||||||||||||||||||
| Metal binding | 317 | 1 | Calcium 1 | ||||||||||||||||||||||||||||||||||
| Metal binding | 319 | 1 | Calcium 1 | ||||||||||||||||||||||||||||||||||
| Metal binding | 321 | 1 | Calcium 1; via carbonyl oxygen | ||||||||||||||||||||||||||||||||||
| Metal binding | 326 | 1 | Calcium 1 | ||||||||||||||||||||||||||||||||||
| Metal binding | 352 | 1 | Calcium 2 | ||||||||||||||||||||||||||||||||||
| Metal binding | 353 | 1 | Calcium 2; via amide nitrogen | ||||||||||||||||||||||||||||||||||
| Metal binding | 354 | 1 | Calcium 2 | ||||||||||||||||||||||||||||||||||
| Metal binding | 356 | 1 | Calcium 2 | ||||||||||||||||||||||||||||||||||
| Metal binding | 357 | 1 | Calcium 2; via amide nitrogen | ||||||||||||||||||||||||||||||||||
| Metal binding | 358 | 1 | Calcium 2; via carbonyl oxygen | ||||||||||||||||||||||||||||||||||
| Metal binding | 360 | 1 | Calcium 2 | ||||||||||||||||||||||||||||||||||
| Metal binding | 363 | 1 | Calcium 2 | ||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||
| Modified residue | 323 | 1 | Phosphoserine Ref.8 | ||||||||||||||||||||||||||||||||||
| Lipidation | 2 | 1 | N-myristoyl glycine Potential | ||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 300 | 300 | Missing in isoform Calbrain. | VSP_037936 | |||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 203 | 203 | Missing in isoform S-CaBP1. | VSP_037937 | |||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 143 | 143 | Missing in isoform L-CaBP1. | VSP_037938 | |||||||||||||||||||||||||||||||||
| Alternative sequence | 144 – 218 | 75 | RPREA…SAFGQ → MGNCVKYPLRNLSRKMCQEE QTSYMVVQTSEEGLAADAEL PGPLLMLAQNCAVMHNLLGP ACIFLRKGFAENRQP in isoform L-CaBP1. | VSP_037939 | |||||||||||||||||||||||||||||||||
| Alternative sequence | 204 – 218 | 15 | FLHRL…SAFGQ → MGNCVKYPLRNLSRK in isoform S-CaBP1. | VSP_037940 | |||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||
| Mutagenesis | 238 | 1 | D → A: Loss of magnesium-binding. Loss of binding to ITPRs; when associated with A-240; A-315; A-317; A-352 and A-354. Ref.6 Ref.15 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 240 | 1 | D → A: Loss of magnesium-binding. Loss of binding to ITPRs; when associated with A-238; A-315; A-317; A-352 and A-354. Ref.6 Ref.15 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 242 | 1 | D → A: Loss of magnesium-binding. Ref.15 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 249 | 1 | D → A: No effect on magnesium-binding. Ref.15 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 315 | 1 | D → A: Loss of binding to ITPRs; when associated with A-238; A-240; A-317; A-352 and A-354. Ref.6 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 317 | 1 | N → A: Loss of binding to ITPRs; when associated with A-238; A-240; A-315; A-352 and A-354. Ref.6 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 323 | 1 | S → A: Loss of phosphorylation and loss of calcium release by InsP(3). Ref.8 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 352 | 1 | D → A: Loss of binding to ITPRs; when associated with A-238; A-240; A-315; A-317 and A-354. Ref.6 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 354 | 1 | N → A: Loss of binding to ITPRs; when associated with A-238; A-240; A-315; A-317 and A-352. Ref.6 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 140 | 1 | Q → R in AAH30201. Ref.4 | ||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||
| Helix | 224 – 240 | 17 | |||||||||||||||||||||||||||||||||||
| Beta strand | 242 – 244 | 3 | |||||||||||||||||||||||||||||||||||
| Helix | 247 – 256 | 10 | |||||||||||||||||||||||||||||||||||
| Helix | 263 – 274 | 12 | |||||||||||||||||||||||||||||||||||
| Beta strand | 277 – 279 | 3 | |||||||||||||||||||||||||||||||||||
| Helix | 283 – 294 | 12 | |||||||||||||||||||||||||||||||||||
| Helix | 299 – 302 | 4 | |||||||||||||||||||||||||||||||||||
| Helix | 304 – 314 | 11 | |||||||||||||||||||||||||||||||||||
| Beta strand | 319 – 322 | 4 | |||||||||||||||||||||||||||||||||||
| Helix | 324 – 335 | 12 | |||||||||||||||||||||||||||||||||||
| Beta strand | 337 – 339 | 3 | |||||||||||||||||||||||||||||||||||
| Helix | 341 – 351 | 11 | |||||||||||||||||||||||||||||||||||
| Beta strand | 353 – 359 | 7 | |||||||||||||||||||||||||||||||||||
| Helix | 361 – 367 | 7 | |||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Calbrain, a novel two EF-hand calcium-binding protein that suppresses Ca2+/calmodulin-dependent protein kinase II activity in the brain." Yamaguchi K., Yamaguchi F., Miyamoto O., Sugimoto K., Konishi R., Hatase O. J. Biol. Chem. 274:3610-3616(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CALBRAIN). Tissue: Cerebellum. |
| [2] | "Five members of a novel Ca(2+)-binding protein (CABP) subfamily with similarity to calmodulin." Haeseleer F., Sokal I., Verlinde C.L.M.J., Erdjument-Bromage H., Tempst P., Pronin A.N., Benovic J.L., Fariss R.N., Palczewski K. J. Biol. Chem. 275:1247-1260(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS L-CABP1 AND S-CABP1), MYRISTOYLATION (ISOFORMS L-CABP1 AND S-CABP1). Tissue: Retina. |
| [3] | "The finished DNA sequence of human chromosome 12." Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R. Gibbs R.A.Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CALDENDRIN). |
| [5] | "Caldendrin, a novel neuronal calcium-binding protein confined to the somato-dendritic compartment." Seidenbecher C.I., Langnaese K., Sanmarti-Vila L., Boeckers T.M., Smalla K.-H., Sabel B.A., Garner C.C., Gundelfinger E.D., Kreutz M.R. J. Biol. Chem. 273:21324-21331(1998) [PubMed] [Europe PMC] [Abstract] Cited for: ALTERNATIVE SPLICING (ISOFORM CALDENDRIN). |
| [6] | "Identification of a family of calcium sensors as protein ligands of inositol trisphosphate receptor Ca(2+) release channels." Yang J., McBride S., Mak D.-O.D., Vardi N., Palczewski K., Haeseleer F., Foskett J.K. Proc. Natl. Acad. Sci. U.S.A. 99:7711-7716(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ITPR1; ITPR2 AND ITPR3, MUTAGENESIS OF ASP-238; ASP-240; ASP-315; ASN-317; ASP-352 AND ASN-354. |
| [7] | "Differential modulation of Ca(v)2.1 channels by calmodulin and Ca2+-binding protein 1." Lee A., Westenbroek R.E., Haeseleer F., Palczewski K., Scheuer T., Catterall W.A. Nat. Neurosci. 5:210-217(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH CACNA1A. |
| [8] | "Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins." Kasri N.N., Holmes A.M., Bultynck G., Parys J.B., Bootman M.D., Rietdorf K., Missiaen L., McDonald F., De Smedt H., Conway S.J., Holmes A.B., Berridge M.J., Roderick H.L. EMBO J. 23:312-321(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-323, MUTAGENESIS OF SER-323, SUBCELLULAR LOCATION, INTERACTION WITH ITPR1. |
| [9] | "Calcium-binding protein 1 is an inhibitor of agonist-evoked, inositol 1,4,5-trisphosphate-mediated calcium signaling." Haynes L.P., Tepikin A.V., Burgoyne R.D. J. Biol. Chem. 279:547-555(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [10] | "Caldendrin but not calmodulin binds to light chain 3 of MAP1A/B: an association with the microtubule cytoskeleton highlighting exclusive binding partners for neuronal Ca(2+)-sensor proteins." Seidenbecher C.I., Landwehr M., Smalla K.H., Kreutz M., Dieterich D.C., Zuschratter W., Reissner C., Hammarback J.A., Bockers T.M., Gundelfinger E.D., Kreutz M.R. J. Mol. Biol. 336:957-970(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MAP1LC3B. |
| [11] | "Ca2+-binding protein-1 facilitates and forms a postsynaptic complex with Cav1.2 (L-type) Ca2+ channels." Zhou H., Kim S.-A., Kirk E.A., Tippens A.L., Sun H., Haeseleer F., Lee A. J. Neurosci. 24:4698-4708(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH CACNA1C. |
| [12] | "Molecular mechanism for divergent regulation of Cav1.2 Ca2+ channels by calmodulin and Ca2+-binding protein-1." Zhou H., Yu K., McCoy K.L., Lee A. J. Biol. Chem. 280:29612-29619(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH CACNA1C. |
| [13] | "Inhibition of TRPC5 channels by Ca2+-binding protein 1 in Xenopus oocytes." Kinoshita-Kawada M., Tang J., Xiao R., Kaneko S., Foskett J.K., Zhu M.X. Pflugers Arch. 450:345-354(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH TRPC5. |
| [14] | "Structural analysis of Mg2+ and Ca2+ binding to CaBP1, a neuron-specific regulator of calcium channels." Wingard J.N., Chan J., Bosanac I., Haeseleer F., Palczewski K., Ikura M., Ames J.B. J. Biol. Chem. 280:37461-37470(2005) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT, CALCIUM-BINDING, MAGNESIUM-BINDING. |
| [15] | "Structural insights into Ca2+-dependent regulation of inositol 1,4,5-trisphosphate receptors by CaBP1." Li C., Chan J., Haeseleer F., Mikoshiba K., Palczewski K., Ikura M., Ames J.B. J. Biol. Chem. 284:2472-2481(2009) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 219-294 AND 299-370 IN COMPLEX WITH MAGNESIUM AND CALCIUM, MUTAGENESIS OF ASP-238; ASP-240; ASP-242 AND ASP-249. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X94700 mRNA. Translation: CAA64361.1. AF169148 mRNA. Translation: AAF25782.1. AF169149 mRNA. Translation: AAF25783.1. AC069234 Genomic DNA. No translation available. BC030201 mRNA. Translation: AAH30201.2. | ||||||||||||||||||||||||||||||||||||||||||||||||
| IPI | IPI00003571. IPI00220810. IPI00297321. IPI00472586. | ||||||||||||||||||||||||||||||||||||||||||||||||
| RefSeq | NP_001028849.1. NM_001033677.1. NP_004267.2. NM_004276.4. NP_112482.1. NM_031205.3. | ||||||||||||||||||||||||||||||||||||||||||||||||
| UniGene | Hs.458482. | ||||||||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | Q9NZU7. | ||||||||||||||||||||||||||||||||||||||||||||||||
| SMR | Q9NZU7. Positions 219-370. | ||||||||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| DIP | DIP-35477N. | ||||||||||||||||||||||||||||||||||||||||||||||||
| IntAct | Q9NZU7. 4 interactions. | ||||||||||||||||||||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000317310. | ||||||||||||||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| PhosphoSite | Q9NZU7. | ||||||||||||||||||||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| DMDM | 257051082. | ||||||||||||||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| PaxDb | Q9NZU7. | ||||||||||||||||||||||||||||||||||||||||||||||||
| PRIDE | Q9NZU7. | ||||||||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| DNASU | 9478. | ||||||||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000288616; ENSP00000288616; ENSG00000157782. ENST00000316803; ENSP00000317310; ENSG00000157782. ENST00000351200; ENSP00000288615; ENSG00000157782. | ||||||||||||||||||||||||||||||||||||||||||||||||
| GeneID | 9478. | ||||||||||||||||||||||||||||||||||||||||||||||||
| KEGG | hsa:9478. | ||||||||||||||||||||||||||||||||||||||||||||||||
| UCSC | uc001tyu.3. human. uc001tyv.3. human. uc001tyw.3. human. | ||||||||||||||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| CTD | 9478. | ||||||||||||||||||||||||||||||||||||||||||||||||
| GeneCards | GC12P121078. | ||||||||||||||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:1384. CABP1. | ||||||||||||||||||||||||||||||||||||||||||||||||
| HPA | HPA051438. | ||||||||||||||||||||||||||||||||||||||||||||||||
| MIM | 605563. gene. | ||||||||||||||||||||||||||||||||||||||||||||||||
| neXtProt | NX_Q9NZU7. | ||||||||||||||||||||||||||||||||||||||||||||||||
| PharmGKB | PA26000. | ||||||||||||||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| eggNOG | COG5126. | ||||||||||||||||||||||||||||||||||||||||||||||||
| HOGENOM | HOG000233018. | ||||||||||||||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG012180. | ||||||||||||||||||||||||||||||||||||||||||||||||
| OrthoDB | EOG44BB3F. | ||||||||||||||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| ArrayExpress | Q9NZU7. | ||||||||||||||||||||||||||||||||||||||||||||||||
| Bgee | Q9NZU7. | ||||||||||||||||||||||||||||||||||||||||||||||||
| CleanEx | HS_CABP1. | ||||||||||||||||||||||||||||||||||||||||||||||||
| Genevestigator | Q9NZU7. | ||||||||||||||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000157782. Homo sapiens. | ||||||||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||||||||
| Gene3D | 1.10.238.10. 2 hits. | ||||||||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR011992. EF-hand-like_dom. IPR018247. EF_Hand_1_Ca_BS. IPR002048. EF_hand_dom. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF00036. efhand. 3 hits. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||
| SMART | SM00054. EFh. 3 hits. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||
| PROSITE | PS00018. EF_HAND_1. 3 hits. PS50222. EF_HAND_2. 4 hits. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||||||||||
| ChiTaRS | CABP1. human. | ||||||||||||||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | Q9NZU7. | ||||||||||||||||||||||||||||||||||||||||||||||||
| GenomeRNAi | 9478. | ||||||||||||||||||||||||||||||||||||||||||||||||
| NextBio | 35520. | ||||||||||||||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | CABP1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NZU7 Secondary accession number(s): O95663, Q8N6H5, Q9NZU8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
